Notice of Registration - Manufacturers
2019 - AMRI Renesselaer, Inc. | Cambrex High Point, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Bulk Manufacturer of Controlled Substances Registration
[Docket No. DEA-537]
ACTION: Notice of registration.
SUMMARY: The registrants listed below have applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of a various classes of schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as a bulk manufacturer of various classes of scheduled I and II controlled substances. Information on previously published notices is listed below. No comments or objections were submitted for these notices.
Company | FR Docket | Published |
---|---|---|
AMRI Renesselaer, Inc. | 84 FR 44640 | August 26, 2019 |
Cambrex High Point, Inc. | 84 FR 44639 | August 26, 2019 |
The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies.
Dated: 11/13/2019
William T. McDermott,
Acting Assistant Administrator.